These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21394116)

  • 21. Systemic complement activation in age-related macular degeneration.
    Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
    PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related macular degeneration: a complementopathy?
    Kijlstra A; Berendschot TT
    Ophthalmic Res; 2015; 54(2):64-73. PubMed ID: 26159686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complement system and age-related macular degeneration.
    Sivaprasad S; Chong NV
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of genetic variation in the complement system in age-related macular degeneration.
    de Jong S; Gagliardi G; Garanto A; de Breuk A; Lechanteur YTE; Katti S; van den Heuvel LP; Volokhina EB; den Hollander AI
    Prog Retin Eye Res; 2021 Sep; 84():100952. PubMed ID: 33610747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration.
    Bora NS; Matta B; Lyzogubov VV; Bora PS
    Mol Immunol; 2015 Feb; 63(2):176-83. PubMed ID: 25074023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement System and Potential Therapeutics in Age-Related Macular Degeneration.
    Park YG; Park YS; Kim IB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic targeting of the complement system in age-related macular degeneration: a review.
    Troutbeck R; Al-Qureshi S; Guymer RH
    Clin Exp Ophthalmol; 2012; 40(1):18-26. PubMed ID: 22304025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement system and age-related macular degeneration: drugs and challenges.
    Wu J; Sun X
    Drug Des Devel Ther; 2019; 13():2413-2425. PubMed ID: 31409975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory biomarkers for AMD.
    Stanton CM; Wright AF
    Adv Exp Med Biol; 2014; 801():251-7. PubMed ID: 24664705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related macular degeneration: A disease of extracellular complement amplification.
    de Jong S; Tang J; Clark SJ
    Immunol Rev; 2023 Jan; 313(1):279-297. PubMed ID: 36223117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eye Diseases Direct Interest to Complement Pathway and Macrophages as Regulators of Inflammation in COVID-19.
    Jager MJ; Seddon JM
    Asia Pac J Ophthalmol (Phila); 2020 Dec; 10(1):114-120. PubMed ID: 33290288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
    Kelly U; Yu L; Kumar P; Ding JD; Jiang H; Hageman GS; Arshavsky VY; Frank MM; Hauser MA; Rickman CB
    J Immunol; 2010 Nov; 185(9):5486-94. PubMed ID: 20876352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration.
    Shen D; Tuo J; Patel M; Herzlich AA; Ding X; Chew EY; Chan CC
    Br J Ophthalmol; 2009 Mar; 93(3):405-8. PubMed ID: 18996904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology of age-related macular degeneration.
    Ambati J; Atkinson JP; Gelfand BD
    Nat Rev Immunol; 2013 Jun; 13(6):438-51. PubMed ID: 23702979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.
    Kawa MP; Machalinska A; Roginska D; Machalinski B
    J Immunol Res; 2014; 2014():483960. PubMed ID: 25276841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related macular degeneration: Complement in action.
    van Lookeren Campagne M; Strauss EC; Yaspan BL
    Immunobiology; 2016 Jun; 221(6):733-9. PubMed ID: 26742632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The case for complement and inflammation in AMD: open questions.
    Karagianni N; Adamis AP
    Adv Exp Med Biol; 2010; 703():1-7. PubMed ID: 20711703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids.
    Nashine S; Chwa M; Kazemian M; Thaker K; Lu S; Nesburn A; Kuppermann BD; Kenney MC
    PLoS One; 2016; 11(8):e0159828. PubMed ID: 27486856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement, age-related macular degeneration and a vision of the future.
    Gehrs KM; Jackson JR; Brown EN; Allikmets R; Hageman GS
    Arch Ophthalmol; 2010 Mar; 128(3):349-58. PubMed ID: 20212207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.
    Parmeggiani F; Sorrentino FS; Romano MR; Costagliola C; Semeraro F; Incorvaia C; D'Angelo S; Perri P; De Nadai K; Bonomo Roversi E; Franceschelli P; Sebastiani A; Rubini M
    Mediators Inflamm; 2013; 2013():435607. PubMed ID: 24369445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.